Foghorn Therapeutics News

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-10% Owner Flagship Pioneering Inc.

May 24 17:08 ET

Foghorn Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Noubar Afeyan(22.9%),Flagship Ventures Fund V, L.P.(16.9%), etc.

May 24 17:03 ET

Foghorn Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Flagship Pioneering Fund VII General Partner LLC

May 24 17:02 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Humer Kristian

Apr 17 16:06 ET

Foghorn Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Humer Kristian

Apr 17 16:05 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cavalie Fanny

Mar 12 16:24 ET

Foghorn Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(6.656%),Abigail P. Johnson(6.656%)

Feb 9 09:10 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GOTTSCHALK ADRIAN

Jan 25 16:11 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cardama Alfonso Quintas

Jan 25 16:06 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cavalie Fanny

Jan 25 16:06 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Costa Carlos

Jan 25 16:06 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bellon Steven F.

Jan 25 16:06 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaCascia Michael

Jan 25 16:05 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reine Allan

Jan 17 00:00 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director SMITH IAN F

Dec 12, 2023 16:00 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Agresta Samuel

Sep 13, 2023 16:02 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cardama Alfonso Quintas

Sep 13, 2023 16:01 ET

Foghorn Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Cardama Alfonso Quintas

Sep 13, 2023 16:00 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Agresta Samuel

Aug 18, 2023 16:03 ET

Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer GOTTSCHALK ADRIAN

Aug 18, 2023 16:03 ET